Regularity in daily mood stabilizer dosage taken by patients with bipolar disorder

Pharmacopsychiatry

Volumn 46, Issue 5, 2013, Pages 163-168

  Bauer, M ^a   Glenn, T ^b   Alda, M ^c   Sagduyu, K ^d   Marsh, W ^e   Grof, P ^f,j   Munoz, R ^g   Baethge, C ^h   Lewitzka, U ^a   Pilhatsch, M ^a   Bauer, R ^a   Whybrow, P C ⁱ  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b ChronoRecord Association Inc   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Mood Disorders Center of Ottawa   (Canada)

more..

Author keywords

bipolar disorder; dosage; mood stabilizers

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OXCARBAZEPINE; PREGABALIN; PSYCHOTROPIC AGENT; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ARTICLE; BIPOLAR DISORDER; DEPRESSION; ENTROPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PILL; PRIORITY JOURNAL;

ADULT; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MODELS, STATISTICAL; PSYCHOTROPIC DRUGS; SELF REPORT;

EID: 84879929700     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0033-1343398     Document Type: Article

References (49)

1. DiMatteo M. R. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care: 2004; 42 200 209
2. Lingam R., Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand: 2002; 105 164 172 (Pubitemid 34280688)
3. Scott J., Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry: 2002; 63 384 390 (Pubitemid 34507214)
4. Sajatovic M., Valenstein M., Blow F. et al. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder. Psychiatr Serv: 2007; 58 855 863 (Pubitemid 46985180)
5. Berk L., Hallam K. T., Colom F. et al. Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol: 2010; 25 1 16
6. Busby K. K., Sajatovic M. REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literature. CNS Neurosci Ther: 2010; 16 308 315
7. Gutiérrez-Rojas L., Jurado D., Martínez-Ortega J. M. et al. Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. J Affect Disord: 2010; 127 77 83
8. Keck P. E. Jr, McElroy S. L., Strakowski S. M. et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry: 1998; 155 646 652 (Pubitemid 28225405)
9. Hassan M., Lage M. J. Risk of rehospitalization among bipolar disorder patients who are non-adherent to antipsychotic therapy after hospital discharge. Am J Health Syst Pharm: 2009; 66 358 365
10. Schuepbach D., Novick D., Haro J. M. et al. Determinants of voluntary vs. involuntary admission in bipolar disorder and the impact of adherence. Pharmacopsychiatry: 2008; 41 29 36
11. Scott J., Pope M. Self-Reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry: 2002; 159 1927 1929 (Pubitemid 35283261)
12. Gonzalez-Pinto A., Mosquera F., Alonso M. et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord: 2006; 8 618 624 (Pubitemid 44567143)
13. Sajatovic M., Velligan D. I., Weiden P. J. et al. Measurement of psychiatric treatment adherence. J Psychosom Res: 2010; 69 591 599
14. Baldessarini R. J., Perry R., Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol: 2008; 23 95 105 (Pubitemid 351359581)
15. González-Pinto A., Reed C., Novick D. et al. Assessment of medication adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry: 2010; 43 263 270
16. Jónsdóttir H., Opjordsmoen S., Birkenaes A. B. et al. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharmacol: 2010; 30 169 175
17. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med: 2005; 353 487 497 (Pubitemid 41127293)
18. Kikkert M. J., Barbui C., Koeter M. W. et al. Assessment of medication adherence in patients with schizophrenia: the Achilles heel of adherence research. J Nerv Ment Dis: 2008; 196 274 281 (Pubitemid 351548727)
19. Pomykacz B., Mao M., Weiss R. D. et al. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harv Rev Psychiatry: 2007; 15 259 263 (Pubitemid 47557205)
20. Velligan D., Sajatovic M., Valenstein M. et al. Methodological challenges in psychiatric treatment adherence research. Clin Schizophr Relat Psychoses: 2010; 4 74 91
21. Levy G. Medication non-compliance: When hard science meets soft science. International Congress Series 2001: 1220; 125 133
22. Bauer M., Glenn T., Keil M. et al. Brief depressive symptoms in patients with bipolar disorder: analysis of long-term self-reported data. Aust N Z J Psychiatry: 2012; 46 1068 1078
23. Bauer M., Grof P., Gyulai L. et al. Using technology to improve longitudinal studies: self-reporting with chronorecord in bipolar disorder. Bipolar Disord: 2004; 6 67 74 (Pubitemid 38256506)
24. Bauer M., Wilson T., Neuhaus K. et al. Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania. Psychiatry Res: 2008; 159 359 366
25. Pincus S. M. Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA: 1991; 88 2297 2301 (Pubitemid 21916403)
26. Pincus S. M., Gladstone I. M., Ehrenkranz R. A. A regularity statistic for medical data analysis. J Clin Monit: 1991; 7 335 345
27. Pincus S. M., Goldberger A. L. Physiological time-series analysis: what does regularity quantify? Am J Physiol: 1994; 266 H1643 H1656 (Pubitemid 24150798)
28. Pan W., Connett J. E. Selecting the working correlation structure in generalized estimating equations with application to the lung health study. Statistica Sinica: 2002; 12 475 490 (Pubitemid 36116180)
29. Harter J. G., Peck C. C. Chronobiology. Suggestions for integrating it into drug development. Ann N Y Acad Sci: 1991; 618 563 571
30. Osterberg L. G., Urquhart J., Blaschke T. F. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics. Clin Pharmacol Ther: 2010; 88 457 459
31. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J: 1996; 17 (Suppl A): 8 15 (Pubitemid 26129713)
32. Bauer M., Glenn T., Grof P. et al. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder. Hum Psychopharmacol: 2010; 25 47 54
33. Johnson F. R., Ozdemir S., Manjunath R. et al. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Med Care: 2007; 45 545 552
34. Ingersoll K. S., Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med: 2008; 31 213 224
35. Gianfrancesco F. D., Sajatovic M., Tafesse E. et al. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder. Ann Clin Psychiatry: 2009; 21 3 16
36. Sajatovic M., Bauer M. S., Kilbourne A. M. et al. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv: 2006; 57 56 62 (Pubitemid 43053837)
37. Cramer J. A., Rosenheck R. Enhancing medication compliance for people with serious mental illness. J Nerv Ment Dis: 1999; 187 53 55 (Pubitemid 29063085)
38. Gaudiano B. A., Weinstock L. M., Miller I. W. Improving treatment adherence in bipolar disorder: a review of current psychosocial treatment efficacy and recommendations for future treatment development. Behav Modif: 2008; 32 267 301
39. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J: 1992; 68 03 S49 S58
40. Claxton A. J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther: 2001; 23 1296 1310 (Pubitemid 32804122)
41. Saini S. D., Schoenfeld P., Kaulback K. et al. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care: 2009; 15 e22 e33
42. Richter A., Anton S. E., Koch P. et al. The impact of reducing dose frequency on health outcomes. Clin Ther: 2003; 25 2307 2335 (Pubitemid 37076322)
43. Levy G. A pharmacokinetic perspective on medicament noncompliance. Clin Pharmacol Ther: 1993; 54 242 244 (Pubitemid 23294523)
44. Bialer M. Extended-release formulations for the treatment of epilepsy. CNS Drugs: 2007; 21 765 774 (Pubitemid 47294721)
45. van Berge Henegouwen M. T., van Driel H. F., Kasteleijn-Nolst Trenité D. G. A patient diary as a tool to improve medicine compliance. Pharm World Sci: 1999; 21 21 24 (Pubitemid 29161695)
46. Lam D. H., Watkins E. R., Hayward P. et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry: 2003; 60 145 152 (Pubitemid 36173120)
47. Garber M. C., Nau D. P., Erickson S. R. et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care: 2004; 42 649 652
48. Kupka R. W., Altshuler L. L., Nolen W. A. et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord: 2007; 9 531 535 (Pubitemid 47202517)
49. Judd L. L., Akiskal H. S., Schettler P. J. et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry: 2002; 59 530 537 (Pubitemid 34602935)